Kuss, M <br/><br/>
Hemostatic and fibrinolytic effects of systemic prostaglandin E1 therapy in patients with peripheral arterial disease.  [electronic resource] 

 -  VASA. Zeitschrift fur Gefasskrankheiten  Aug 2003 
 - 145-8 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0301-1526 
<br/><br/><label>Standard No.: </label>10.1024/0301-1526.32.3.145  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Alprostadil--administration & dosage<br/>Arterial Occlusive Diseases--blood<br/>Blood Coagulation Factors--metabolism<br/>Blood Coagulation Tests<br/>Female<br/>Fibrinolysis--drug effects<br/>Fibrinolytic Agents--adverse effects<br/>Hemorrhage--blood<br/>Hemostasis--drug effects<br/>Humans<br/>Infusions, Intravenous<br/>Male<br/>Middle Aged<br/>Risk Assessment